Product Reports Resources Pricing Login Book a demo

iSpecimen

Biotech & Life Sciences · Lexington, United States · Founded 2012 · IPO 2021

Marketplace for human biospecimens, providing researchers with the samples they need from the patients they want MoreLess

iSpecimen operates an innovative platform that connects researchers with a diverse network of biospecimen providers, facilitating the acquisition of high-quality biological samples essential for medical research and development. Serving academic institutions, pharmaceutical companies, and diagnostic labs, iSpecimen operates in the life sciences and healthcare markets. The business model revolves around a marketplace approach, where researchers can search, request, and obtain biospecimens from various providers. Revenue is generated through transaction fees and service charges for sample procurement and data management. The platform ensures compliance with regulatory standards and offers a streamlined process for both researchers and providers, enhancing the efficiency of medical research.

Keywords: biospecimen, medical research, healthcare, life sciences, marketplace, academic institutions, pharmaceutical companies, diagnostic labs, regulatory compliance, data management.

Revenue $1.9M
Total funding $10–50M

Talent graph

iSpecimen's talent

Book a demo to see the people
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

1 investor on iSpecimen's cap table

Sourced from Dealroom's funding and investor records.

Series A 1 investor entered at this stage
MassChallenge

Global footprint

Where iSpecimen has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States81.8%
🇨🇦 Canada9.1%
2 countries shown

Market sentiment

What the market is saying about iSpecimen

An AI-synthesized read of the highest-engagement posts about iSpecimen on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See iSpecimen on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.